ISOTYPE CHARACTERIZATION OF ANTI-INFLIXIMAB ANTIBODIES IN PEDIATRIC PATIENTS WITH RHEUMATIC DISEASES TREATED WITH INFLIXIMAB

被引：0
|
作者：
Kosmac, M. [1 ,2 ,3 ]
Toplak, N. [3 ]
Simonini, G. [4 ,5 ]
Cimaz, R. [4 ,5 ]
Serbec, V. Curin [1 ,2 ]
Avcin, T. [3 ]
机构：
[1] Blood Transfus Ctr Slovenia, Dept Prod Diagnost Reagents & Res, Ljubljana, Slovenia
[2] Univ Ljubljana, Fac Chem & Chem Technol, Ljubljana 61000, Slovenia
[3] Univ Childrens Hosp, Univ Med Ctr, Dept Allergol Rheumatol & Clin Immunol, Ljubljana, Slovenia
[4] Anna Meyer Childrens Hosp, Rheumatol Unit, Florence, Italy
[5] Univ Florence, Florence, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 71卷
关键词：
D O I：
10.1136/annrheumdis-2012-eular.2260
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：255 / 255
页数：1
相关论文
共 50 条
  • [21] The Clinical and Immunological Significance of Low Level of Infliximab in the Absence of Anti-Infliximab Antibodies in Patients With IBD
    Ungar, Bella
    Anafy, Adi
    Kopylov, Uri
    Ron, Yulia
    Yanai, Henit
    Dotan, Iris
    Chowers, Yehuda
    Eliakim, Abraham R.
    Ben-Horin, Shomron
    [J]. GASTROENTEROLOGY, 2014, 146 (05) : S245 - S245
  • [22] Clinical Response in Rheumatoid Arthritis Patients with Anti-Infliximab Antibodies
    Opris, Daniela
    Mazilu, Diana
    Ionescu, Ruxandra
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (04) : S40 - S41
  • [23] ANTI-INFLIXIMAB ANTIBODIES IMPAIR CLINICAL RESPONSE TO INFLIXIMAB IN JIA ASSOCIATED UVEITIS
    Metha, R.
    Tay-Kearney, M.
    Manners, P.
    Murray, K.
    [J]. INTERNAL MEDICINE JOURNAL, 2012, 42 : 32 - 33
  • [24] Infusion reactions during infliximab treatment are not associated with IgE anti-infliximab antibodies
    van Schie, Karin A.
    Heer, Pleuni Ooijevaar-De
    Kruithof, Simone
    Plasencia, Chamaida
    Jurado, Teresa
    Salcedo, Dora Pascual
    Brandse, Johannan F.
    d'Haens, Geert R. A. M.
    Wolbink, Gerrit Jan
    Rispens, Theo
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (07) : 1285 - 1288
  • [25] Influence of anti-infliximab antibodies and residual infliximab concentrations on the occurrence of acquired drug resistance to infliximab in rheumatoid arthritis patients
    Finckh, Axel
    Dudler, Jean
    Wermelinger, Felix
    Ciurea, Adrian
    Kyburz, Diego
    Gabay, Cem
    Bas, Sylvette
    [J]. JOINT BONE SPINE, 2010, 77 (04) : 313 - 318
  • [26] Detection of infliximab levels and anti-infliximab antibodies: a comparison of three different assays
    Casteele, N. Vande
    Buurman, D. J.
    Sturkenboom, M. G. G.
    Kleibeuker, J. H.
    Vermeire, S.
    Rispens, T.
    van der Kleij, D.
    Gils, A.
    Dijkstra, G.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (08) : 765 - 771
  • [27] Letter: detection of infliximab levels and anti-infliximab antibodies comparison of three different assays
    Parussini, E.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (02) : 281 - 281
  • [28] Can Measurements of Anti-Infliximab Antibodies Predict Acute Severe Infusion Reactions to Infliximab?
    Steenholdt, Casper
    Svenson, Morten
    Bendtzen, Klaus
    Thomsen, Ole
    Brynskov, Jorn
    Ainsworth, Mark A.
    [J]. GASTROENTEROLOGY, 2011, 140 (05) : S774 - S774
  • [29] An Optimized Anti-infliximab Bridging Enzyme-linked Immunosorbent Assay for Harmonization of Anti-infliximab Antibody Titers in Patients with Inflammatory Bowel Diseases
    Van Stappen, Thomas
    Billiet, Thomas
    Vande Casteele, Niels
    Compernolle, Griet
    Brouwers, Els
    Vermeire, Severine
    Gils, Ann
    [J]. INFLAMMATORY BOWEL DISEASES, 2015, 21 (09) : 2172 - 2177
  • [30] Development of anti-infliximab antibodies increases infliximab clearance in chronic inflammatory bowel disease
    Ternant, D.
    Aubourg, A.
    Magdelaine-Beuzelin, C.
    Degenne, D.
    Watier, H.
    Picon, L.
    Paintaud, G.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 : 23 - 23
12345